Skip to content
Welcome to Heart Matters - Empowering Heart Health
Conditions

Understanding Hypertrophic Cardiomyopathy: Causes, Symptoms, and Management

Hypertrophic cardiomyopathy (HCM) is a condition where the walls of the heart become abnormally thick, leading to a variety of symptoms and potential complications. It’s a relatively common genetic disease that affects people of all ages and can be life-threatening if not managed properly. In this article, we’ll explore the causes, symptoms, and some treatment options of HCM.

Causes

Hypertrophic Cardiomyopathy (HCM) stems from mutations in one or more genes, impacting the proteins that govern the heart muscle’s structure. These genetic mutations result in the thickening of heart muscles, impeding the heart’s efficiency in pumping blood. It’s important to emphasize to patients that an enlarged heart muscle isn’t necessarily advantageous and can lead to heart weakening and symptomatic manifestations. HCM follows an inherited pattern and is transmitted within families in an autosomal dominant manner. This signifies that the disease develops with just one copy of the mutated gene, underscoring the genetic link to its occurrence.

Hypertrophic cardiomyopathy (HCM) leads to the walls of the heart’s main pumping chamber becoming thicker than usual (left ventricular hypertrophy). This can happen without any apparent reasons and is frequently coupled with a non-dilated left ventricle featuring preserved or heightened ejection fraction (a measure of the strength of the heart). One thing about HCM is that it usually makes the heart’s walls thicker unevenly, with the lower part of the wall between the chambers being the most affected (asymmetric septal hypertrophy).

Looking at HCM under a microscope, we see that the heart muscle cells become more extensive, and their arrangement can be disorganized. There’s also some extra fibrous tissue in between these cells. This might lead to the heart’s lower chamber not relaxing as well as it should between beats (known as diastolic dysfunction).

The figure presents a side-by-side comparison of a normal heart and a heart model displaying significant hypertrophy of the interventricular septum, a Hypertrophic Cardiomyopathy (HCM) hallmark. The average heart demonstrates balanced chamber sizes and wall thickness. In contrast, the HCM heart model reveals pronounced thickening of the interventricular septum, indicative of the abnormal structural changes associated with HCM.

Symptoms

Many people with HCM have no symptoms; the condition is only discovered when undergoing a routine medical examination. However, when symptoms do occur, they can include:

  • Shortness of breath, especially during physical activity or exertion
  • Chest pain or discomfort
  • Fainting, especially during physical activity or exertion
  • Heart palpitations, which can feel like a rapid or fluttering heartbeat. Atrial fibrillation, a familiar irregular heart rhythm, can also be seen.
  • Fatigue or weakness
  • Swelling in the ankles, feet, or legs
  • Dizziness or lightheadedness

Complications

HCM can lead to a variety of complications, including:

  • Arrhythmias: Irregular heart rhythms that can cause the heart to beat too fast or too slow, leading to dizziness, fainting, or even sudden cardiac arrest.
  • Heart failure: The thickened heart muscle can make it harder for the heart to pump blood, leading to fatigue, shortness of breath, and fluid buildup in the lungs.
  • Obstructive HCM: In some cases, the thickened heart muscle can obstruct blood flow, leading to chest pain, shortness of breath, and fainting.
  • Mitral valve regurgitation: is a common observation often associated with HCM. In this scenario, the abnormally thickened heart walls can affect the proper functioning of the mitral valve, leading to the backflow of blood and resultant regurgitation.

 

Empowering individuals with HCM through knowledge about the genetic facets of the condition and its potential inheritance is paramount for informed decision-making and family health.

 

Treatment

The treatment of HCM depends on the severity of the condition and the presence of symptoms. In most cases, treatment focuses on managing symptoms and preventing complications. Most HCM patients don’t experience noticeable symptoms and usually don’t need medication. Nevertheless, it’s essential to inform those diagnosed with HCM about the genetic aspect of the condition and the potential for passing it on to their children.

Treatments may include:

  • Medications: Beta-blockers, calcium channel blockers, and other prescribed drugs are adept at easing symptoms and averting potential complications. Notably, a novel medicine called Mavacamten has earned regulatory approval, including from the FDA, for patients grappling with significant pressure elevation within the left ventricular chamber due to HCM. This innovative drug has exhibited efficacy in alleviating symptoms and reducing pressures. For a deeper dive into this topic, we invite you to watch our informative YouTube video below.
  • Implantable devices: A pacemaker or implantable cardioverter-defibrillator (ICD) may be recommended for people who have arrhythmias or are at higher risk, such as those with significantly greater left ventricular size/mass or demonstrate episodes of non-sustained ventricular tachycardia (NSVT). For more information on VT, please check out our article here.
  • Surgery: In severe cases, surgery may be needed to remove part of the thickened heart muscle obstructing blood flow. This procedure is known as surgical septal myectomy.
  • Alcohol septal ablation: This may have a role for select patients, although is less frequently used first-line nowadays.
  • Lifestyle changes: Avoiding strenuous physical activity and reducing stress can help prevent symptoms and complications. Avoiding dehydration can also assist.

 

YouTube player

 

Conclusion

In conclusion, HCM is a common genetic condition that affects the heart’s ability to pump blood effectively. While many people with HCM have no symptoms, it can lead to various complications, including arrhythmias, heart failure, and obstructive HCM. Treatment focuses on managing symptoms and preventing complications, including medications, implantable devices, surgery, and lifestyle changes. If you or someone you love has been diagnosed with HCM, it is important to work closely with a healthcare professional to develop a treatment plan tailored to your needs.

About the author

Heart Matters, edited by cardiologist Professor Peter Barlis, is a trusted resource that offers clear and accurate information on cardiovascular health. It bridges the gap between scientific research and everyday understanding, empowering you to make informed choices and take an active role in supporting your heart health.

Our Youtube Channel

Discover our Heart Matters YouTube channel, where we bring heart health to life. From explaining common conditions and symptoms to discussing the latest research, our engaging videos simplify complex topics, ensuring you have access to valuable knowledge for a healthier heart. Subscribe now and embark on a journey of education, empowerment, and inspiration.

Editor's Picks

informing hearts
empowering lives

Subscribe to our newsletter and be the first to receive valuable insights, tips, and resources on heart health.

other anti-anginals

When first-line therapies for angina, such as beta blockers, calcium channel blockers, and nitrates, prove inadequate or are not well-tolerated, second-line therapies may be considered.
Perhexiline is a unique medication that enhances the heart's ability to utilize fatty acids for energy, reducing its reliance on oxygen and lowering oxygen demand. This action helps improve blood flow and alleviates chest pain in some patients with refractory angina.
Nicorandil is another second-line option with a dual mechanism of action. It opens potassium channels in smooth muscle cells, causing vasodilation and enhancing coronary blood flow. Additionally, nicorandil also stimulates nitric oxide release, further dilating blood vessels and reducing heart workload.
Trimetazidine is an anti-ischemic agent that improves cardiac efficiency by enhancing glucose metabolism and shifting the heart's energy production to a more oxygen-efficient process. As second-line therapies, these medications offer alternative approaches for managing angina in individuals who do not respond adequately to first-line treatments or those experiencing side effects from other medications.

lipid lowering therapies

Lipid-lowering therapies are essential in managing coronary artery disease (CAD), a condition where the arteries supplying blood to the heart become narrowed. Among the most commonly prescribed treatments are statins, which reduce cholesterol production in the liver and significantly lower the risk of heart attacks and strokes.

Other medications may be used to target different aspects of lipid metabolism:

  • Ezetimibe helps reduce the absorption of cholesterol in the gut
  • Fibrates lower triglyceride levels
  • Niacin can help raise high-density lipoprotein (HDL) cholesterol

In recent years, a newer class of medications known as PCSK9 inhibitors—such as Repatha (evolocumab)—has become available. These drugs block a specific enzyme involved in cholesterol regulation and can dramatically lower LDL cholesterol, particularly in patients who do not achieve target levels with statins alone.

Together, these therapies provide a range of options to personalise treatment and improve cardiovascular outcomes.

Nitrates

Nitrates for Angina Relief

Nitrates are widely used to treat angina and provide quick relief from chest pain. These medications are commonly available as sublingual sprays or tablets, skin patches, and long-acting tablets.

Nitrates work by dilating blood vessels, allowing for increased blood flow and reduced vascular resistance. This reduces the heart’s workload and lowers its oxygen demand, offering prompt relief from angina symptoms.

Sublingual nitrates act quickly and are typically used at the onset of angina symptoms, while patches and long-acting tablets are used for ongoing prevention.

Common side effects include headaches, dizziness, and flushing. These often improve with continued use but should be discussed with a healthcare provider if persistent or bothersome.

calcium channel blockers

Calcium channel blockers, including amlodipine, felodipine, Cardizem (diltiazem), and verapamil, are commonly prescribed for the treatment of angina.

These medications work by inhibiting the influx of calcium into the muscle cells of the heart and blood vessels, causing them to relax. This relaxation leads to the widening of blood vessels, which improves blood flow and reduces blood pressure.

For individuals with angina, calcium channel blockers reduce the heart’s workload and oxygen demand, helping to relieve chest pain and prevent angina episodes.

While effective, they may cause side effects such as headaches, dizziness, facial flushing, and ankle swelling. These effects should be monitored and discussed with your healthcare provider if they persist.

Beta blockers

Beta blockers, such as metoprolol, propranolol, atenolol, carvedilol, and bisoprolol, play a crucial role in managing angina.

These medications work by blocking specific receptors in the heart, which slows the heart rate and reduces the strength of each contraction. This results in a lower oxygen demand by the heart and helps relieve chest pain associated with angina.

Beta blockers are highly effective in both relieving symptoms and preventing angina episodes. However, they may cause side effects in some individuals, including tiredness, worsened asthma symptoms, more vivid dreams, and erectile dysfunction in some males.

It is important to consult your healthcare provider to determine whether beta blockers are a suitable option for your angina and overall heart health.

Anti-platelet Medications

Anti-platelet medications play a crucial role in preventing blood clot formation and reducing the risk of serious cardiovascular events such as heart attacks and strokes. Commonly used agents include aspirin, clopidogrel, and ticagrelor.

 

Aspirin: This well-known medication inhibits platelet activation, reducing the likelihood that platelets will clump together and form clots. It is widely used for both primary and secondary prevention of heart attacks and strokes.

 

Clopidogrel: A potent anti-platelet agent, clopidogrel works by blocking specific receptors on platelets to prevent aggregation. It is commonly prescribed for patients with acute coronary syndrome, those undergoing stent placement, and some individuals with peripheral arterial disease.

 

Ticagrelor: Ticagrelor also inhibits platelet activation and is typically used in the treatment of acute coronary syndrome. It is often prescribed alongside aspirin to provide dual anti-platelet therapy and further reduce the risk of heart-related events.